Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Renal Failure Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02019719
What this trial is testing

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anaemia
GlaxoSmithKline 97
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Testing effectiveness (Phase 2)Looking for participantsNCT07725497
What this trial is testing

Luspatercept in People With Anemia

Who this might be right for
AnemiaChronic Kidney Disease
Memorial Sloan Kettering Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT02962648
What this trial is testing

An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®)

Who this might be right for
Iron Deficiency AnemiaIron Deficiency Anaemia
Pharmacosmos A/S 103
Large-scale testing (Phase 3)Study completedNCT03418168
What this trial is testing

Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 51
Testing effectiveness (Phase 2)UnknownNCT02366325
What this trial is testing

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis

Who this might be right for
Chronic Renal FailureAnemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Not applicableEnded earlyNCT05315908
What this trial is testing

COVID-19 Testing in Underserved and Vulnerable Populations

Who this might be right for
Heart FailureCoronary Artery DiseaseCancer+5 more
Jesse Nodora 9,120
Not applicableStudy completedNCT03220685
What this trial is testing

Relationship Between Gut Microbiota And Anemia In Patients With Chronic Renal Failure

Who this might be right for
Gut Micrbota and Its Relation to Anemia of CKD Patients
Assiut University 50
Not applicableStudy completedNCT00211068
What this trial is testing

Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa

Who this might be right for
Pure Red-cell Aplasia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 124
Post-approval studies (Phase 4)Study completedNCT03236246
What this trial is testing

KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)

Who this might be right for
Chronic Kidney DiseasesIron Deficiency Anemia
Keryx Biopharmaceuticals 206
Large-scale testing (Phase 3)Study completedNCT04012957
What this trial is testing

Desidustat in the Treatment of Anemia in CKD

Who this might be right for
Chronic Kidney Disease Stage 3AnemiaChronic Kidney Disease Stage 4+1 more
Zydus Lifesciences Limited 588
Large-scale testing (Phase 3)Study completedNCT00090753
What this trial is testing

Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 1,228
Post-approval studies (Phase 4)Study completedNCT00111995
What this trial is testing

Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis

Who this might be right for
Chronic Renal FailureAnemia
Amgen 400
Post-approval studies (Phase 4)Ended earlyNCT01817699
What this trial is testing

Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationAnemiaVitamin D Deficiency+1 more
CANDLE-KIT Trial Study Group 161
Large-scale testing (Phase 3)Study completedNCT00121602
What this trial is testing

Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

Who this might be right for
AnemiaKidney Disease
Amgen 446
Large-scale testing (Phase 3)Study completedNCT00597584
What this trial is testing

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 823
Post-approval studies (Phase 4)Study completedNCT00028093
What this trial is testing

Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Large-scale testing (Phase 3)Study completedNCT01887600
What this trial is testing

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

Who this might be right for
Anemia in Chronic Kidney Disease in Non-dialysis Patients
Astellas Pharma Europe B.V. 594
Not applicableStudy completedNCT05699109
What this trial is testing

Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

Who this might be right for
Anemia of Chronic Kidney DiseaseChronic Renal FailureChronic Renal Failure Anemia
Helwan University 127
Not applicableStudy completedNCT02136563
What this trial is testing

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents

Who this might be right for
Renal AnemiaChronic Kidney Disease
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,000
Next Page